09/09/2025 11:11
Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase

Promega Corporation has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA analysis, the enzyme will enhance Promega capabilities to manufacture and deliver both catalog and customized solutions for clinical, applied and pharmaceutical molecular applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908209296/en/...

09/09/2025 11:00
IFF launches interactive platform to inspire adult beverage innovation

IFF (NYSE: IFF), a global leader in food, beverage, health and wellness, has unveiled SipScape, a new platform designed to inspire innovation across the rapidly evolving adult beverage landscape. It offers actionable insights and trends, including product design, flavor modulation and sweetness reduction in no-and low-alcohol beverages. The platform also highlights IFF’s expertise in incorporating botanicals, natural colors and other functional additions based on current trends and market deman...

09/09/2025 11:00
Kinaxis Powers Shimadzu’s Supply Chain Advancement for the Modern Manufacturing Era

Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Shimadzu Corporation, a top manufacturer of high-technology precision instruments, has selected the Kinaxis Maestro® platform to advance its supply chain strategy and outmaneuver global trade volatility. Shimadzu is turning to Maestro to simulate real-world trade scenarios, align cross-functional teams and proactively act before disruption hits. Shimadzu makes precision equipment for high-stakes...

09/09/2025 11:43
France Grants Reimbursed Compassionate Access (AAC) for Agenus’ BOT/BAL in Refractory MSS Metastatic Colorectal Cancer

Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable (MSS) metastatic colorectal cancer (mCRC) under France’s compassionate access (Accès compassionnel, or AAC) framework. The French National Agency of Medicines and Health Products Safety’s (ANSM) listings for botensilimab and balstilimab are live and detail eligibility (includin...

09/09/2025 11:45
Owlet Makes Premium Monitoring Possible for Every Family With New Dream Sight™ Video Monitor

Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, announces the launch of its new HD video baby monitor, Dream Sight™, and next-generation Dream Duo™. These products represent an important step for Owlet in the category, featuring advanced technology designed to provide clarity, connection, and peace of mind from day one. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909618049/en/Owlet'...

09/12/2025 11:00
Kinaxis Announces New Partnership with Workday to Unite Supply Chain, Finance and Workforce Planning

Kinaxis Inc. (TSX: KXS), an AI leader in supply chain orchestration, today announced a new partnership with Workday that will combine an AI-enabled, agentic framework across Kinaxis Maestro® and Workday Adaptive Planning. This will give customers a unified view of their operational, finance, and people data to drive faster, more confident decisions. Business leaders today face increasing disruption and uncertainty, yet critical functions still operate in silos. Supply chain, finance, and HR o...